Brind.
  1. Castle Biosciences and SciBase are advancing their work in the skin cancer market, with clinical studies entering the next phase and sales increasing.

EIS, SciBase Holding AB, and Castle Biosciences established a collaboration in 2025 to utilize advanced EIS technology in their joint studies.

2 reports, 1 independent Updated Sep 8
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

EIS, SciBase Holding AB, and Castle Biosciences established a collaboration in 2025 to utilize advanced EIS technology in their joint studies.

Who's involved

What this event is mainly about
EIS

Keep exploring

Part of

Castle Biosciences and SciBase are advancing their work in the skin cancer market, with clinical studies entering the next phase and sales increasing. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story